REXO2 has a 3′-to-5′ exonuclease activity, and its dysregulation leads to tumorigenesis of pheochromocytoma by disturbing the DNA replication, recombination, and repair processes (Laitman et al., 2020). The gene discussed is REXO2; the disease is pheochromocytoma.